Dr Abdul Mannan: Patient Has CAPS with 7000 Platelets – Do You Anticoagulate?
Dr Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared a post on LinkedIn:
“Platelets 7,000. Your patient has CAPS (Catastrophic Antiphospholipid Syndrome). Do you anticoagulate?
This is the dilemma every haematologist dreads.
Catastrophic APS (CAPS) throws you into a perfect storm: sky-high thrombotic risk meets dangerous bleeding territory. The instinct is to anticoagulate aggressively. But at 7,000 platelets, that can be fatal.
Here’s the “Bridge to Anticoagulation” approach:
Step 1: HOLD and TRANSFUSE
Stop therapeutic anticoagulation
Give platelet transfusions (unlike TTP, this is safe in CAPS)
Continue immunosuppression and plasma exchange
Step 2: Watch the Safety Window
Platelets <20k: Hold anticoagulation, continue triple therapy
Platelets 20-50k: Consider prophylactic dosing
Platelets >50k: Resume therapeutic anticoagulation
Step 3: Choose UFH
Short half-life, reversible with protamine
Avoid LMWH and warfarin initially
Rule out HIT if platelet recovery stalls
Fourth line: Eculizumab If platelets stay below 20k despite triple therapy, think complement-mediated microangiopathy. Eculizumab can be a lifesaver here.
The bottom line? Don’t let fear of thrombosis push you into fatal bleeding at 7,000. Build the platelet bridge first.
CAPS Task Force recommendations (2020) and real-world experience support this stepwise approach.
Have you managed CAPS with severe thrombocytopenia? What was your strategy?”

More posts from Dr Abdul Mannan on Hemostasis Today.
-
Nov 21, 2026, 20:00Jeyda Star: The FAST Signs of Stroke and the Reality of Life Afterward
-
Nov 21, 2026, 19:59Daniel Lindholm: Women Showed the Largest Improvement in Stroke Risk Over Time in Heart Failure
-
Nov 21, 2026, 19:56Neil Arrowsmith: Raising Awareness of Pulmonary Embolism in Young People
-
Nov 21, 2026, 19:52Muhammad Zeeshan Jamal: Thrilled to Present Our Research on Intermediate-Risk Acute PE in Abu Dhabi
-
Nov 21, 2026, 19:50Mounisha Devireddy: Proud to Share Our Research on High-Risk PE in Pregnancy
-
Nov 21, 2026, 19:47Melissa Hollo: How Severe Anemia Increases the Odds of Acute HF During Pregnancy and Postpartum
-
Nov 21, 2026, 19:44Ashenafi Tazebew Amare: Building Sustainable Systems to Close the Anti-D Immunoglobulin Access Gap in LMICs
-
Nov 21, 2026, 19:43Sheharyar Raza: Interpreting Clotting Times Through Reptilase Time and Thrombin Time Assays
-
Nov 21, 2026, 19:42Minoo Ahmadinejad: Serving on the ISTH 2027 Scientific Theme Committee for Women’s Health